Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Providence County
    4. ›
  4. Providence
    5. ›
  5. EpiVax, Inc.

EpiVax, Inc.

Company claim

Is this your business?

Get access!

Company Details

Name: EpiVax, Inc.
Jurisdiction: Rhode Island
Entity type: Foreign Corporation
Status: Activ
Date of Organization in Rhode Island: 28 Jan 2025 (6 months ago)
Identification Number: 001784841
ZIP code: 02909
City: Providence
County: Providence County
Place of Formation: DELAWARE
Purpose: TO ENGAGE IN THE BUSINESS OF DEVELOPING VACCINE AND THERAPEUTIC DRUG CANDIDATES AND RELATED RESEARCH AND DEVELOPMENT.
Principal Address: Google Maps Logo 188 VALLEY STREET SUITE 424, PROVIDENCE, RI, 02909, USA

Agent

Name Role Address
ANNE DEGROOT Agent 188 VALLEY STREET SUITE 424, PROVIDENCE, RI, 02909, USA

PRESIDENT

Name Role Address
ANNE S DEGROOT PRESIDENT 188 VALLEY ST., STE 424 PROVIDENCE, RI 02909 USA

TREASURER

Name Role Address
ANNE S DEGROOT TREASURER 188 VALLEY ST., STE 424 PROVIDENCE, RI 02909 USA

SECRETARY

Name Role Address
ANNE S DEGROOT SECRETARY 188 VALLEY ST., STE 424 PROVIDENCE, RI 02909 USA

CEO

Name Role Address
RICH-HENRY SCHABOWSKY CEO 188 VALLEY ST., STE 424 PROVIDENCE, RI 02909 USA

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
NLAVQM513F18
CAGE Code:
473V2
UEI Expiration Date:
2025-12-20

Business Information

Activation Date:
2024-12-24
Initial Registration Date:
2005-10-31

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
473V2
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-12-24
CAGE Expiration:
2029-12-24
SAM Expiration:
2025-12-20

Contact Information

POC:
ANNE DE GROOT

Form 5500 Series

Employer Identification Number (EIN):
050499380
Plan Year:
2023
Number Of Participants:
60
Sponsor's telephone number:
4012722123
File:
View File
Plan Administrator / Signatory:
SARAH BOTELHO(Plan administrator)
SARAH BOTELHO(Employer/plan sponsor)
Plan Year:
2022
Number Of Participants:
48
Sponsor's telephone number:
4012722123
File:
View File
Plan Administrator / Signatory:
SARAH BOTELHO(Plan administrator)
Plan Year:
2021
Number Of Participants:
47
Sponsor's telephone number:
4012722123
File:
View File
Plan Administrator / Signatory:
SARAH BOTELHO(Plan administrator)
SARAH BOTELHO(Employer/plan sponsor)
Plan Year:
2020
Number Of Participants:
49
Plan Name:
401(K)
Sponsor's telephone number:
4012722123
File:
View File
Plan Administrator / Signatory:
SARAH BOTELHO(Plan administrator)
Plan Year:
2019
Number Of Participants:
42
Plan Name:
401(K)
Sponsor's telephone number:
4012722123
Plan Administrator / Signatory:
SBOTELHO9973(Plan administrator)

Filings

Number Name File Date
202563338510 Application for Certificate of Authority 2025-01-28

Uniform Commercial Code

The Uniform Commercial Code (UCC) is a comprehensive set of laws governing all commercial transactions in the United States.

A UCC filing is a public notice of a secured transaction. A financing statement indicates a commercial agreement between a debtor and a secured party.

Uniform Commercial Code Summary

Type:
UCC-1 Standard
UCC Filing Number:
202431285230
Filing Date:
2024-11-06
Action:
InitialFiling

Parties

Party Name:
EpiVax, Inc.
Party Role:
Debtor(s)
Party Name:
LEAF CAPITAL FUNDING, LLC
Party Role:
Secured Parties

Uniform Commercial Code Summary

Type:
UCC-3 CONTINUATION
UCC Filing Number:
202330029520
Filing Date:
2023-12-28
Action:
Continuation

Parties

Party Name:
EpiVax, Inc.
Party Role:
Debtor(s)

Uniform Commercial Code Summary

Type:
UCC-1 Standard
UCC Filing Number:
202329767390
Filing Date:
2023-10-18
Action:
InitialFiling

Parties

Party Name:
EpiVax, Inc.
Party Role:
Debtor(s)
Party Name:
LEAF CAPITAL FUNDING, LLC
Party Role:
Secured Parties

USAspending Awards / Contracts

Procurement Instrument Identifier:
HHSF223201300971P
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
$20,561
Base And Exercised Options Value:
$20,561
Base And All Options Value:
$20,561
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2013-09-05
Description:
IGF::OT::IGF HUMAN LEUKOCYTE ANTIGENS (HLA)BINDING STUDY AND IN-VITRO CHARACTERIZATION OF EPITOPES.
Naics Code:
541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Product Or Service Code:
B504: SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
Procurement Instrument Identifier:
W81XWH09C0190
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
$158,128
Base And Exercised Options Value:
$158,128
Base And All Options Value:
$158,128
Awarding Agency Name:
Department of Defense
Performance Start Date:
2009-09-29
Description:
RESEARCH PEPTIDES TO HUMAN MCH ALLELES
Naics Code:
541990: ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
Product Or Service Code:
AN91: OTHER MEDICAL (BASIC)
Procurement Instrument Identifier:
W81XWH09P0071
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
$60,000
Base And Exercised Options Value:
$60,000
Base And All Options Value:
$60,000
Awarding Agency Name:
Department of Defense
Performance Start Date:
2008-11-13
Description:
WEBSITE
Naics Code:
541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Product Or Service Code:
6640: LABORATORY EQUIPMENT AND SUPPLIES

USAspending Awards / Financial Assistance

Business Type:
SMALL BUSINESS
Date:
2012-08-31
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
INDUCING TOLERANCE TO ENZYME REPLACEMENT THERAPY FOR POMPE DISEASE
Obligated Amount:
$600,000
Face Value Of Loan:
$0
Total Face Value Of Loan:
$0
Business Type:
SMALL BUSINESS
Date:
2012-07-10
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
COMBINED FACTOR VIII REPLACEMENT AND TOLERANCE THERAPY FOR HEMOPHILIA A
Obligated Amount:
$757,712
Face Value Of Loan:
$0
Total Face Value Of Loan:
$0
Business Type:
SMALL BUSINESS
Date:
2011-04-28
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
NOVEL H1N1 INFLUENZA PROTECTION VIA CROSS-REACTIVE IMMUNITY
Obligated Amount:
$472,242
Face Value Of Loan:
$0
Total Face Value Of Loan:
$0
Business Type:
SMALL BUSINESS
Date:
2009-09-14
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
OPTIMIZATION OF HIV VACCINE SUBUNIT DELIVERY
Obligated Amount:
$645,115
Face Value Of Loan:
$0
Total Face Value Of Loan:
$0
Business Type:
SMALL BUSINESS
Date:
2012-03-27
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
EPIVAX PHASE II SBIR: PRECLINICAL STUDIES OF TREGITOPE DELIVERY AND MECHANISM OF
Obligated Amount:
$1,474,236
Face Value Of Loan:
$0
Total Face Value Of Loan:
$0

Trademarks

Serial Number:
86879753
Mark:
ACENO BIOTHERAPEUTICS
Status:
Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2016-01-19
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
ACENO BIOTHERAPEUTICS
USPTO Link:
View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:
Pharmaceuticals, biobetters, biosimilars, biopharmaceutical and veterinary preparations for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases
International Classes:
005 - Primary Class
Class Status:
ACTIVE
For:
Research and development of pharmaceuticals, biobetters, biosimilars, biopharmaceutical and veterinary preparations and medicines in the field of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
97231957
Mark:
EPIVAX THERAPEUTICS
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Service Mark
Application Filing Date:
2022-01-21
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
EPIVAX THERAPEUTICS
USPTO Link:
View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:
Research and development of vaccines and medicines; Pharmaceutical research and development; Vaccine research and development
First Use:
2021-02-26
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
90383773
Mark:
PANDA
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Service Mark
Application Filing Date:
2020-12-15
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
PANDA
USPTO Link:
View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:
Scientific and technical services, namely, analysis and testing of protein therapeutic sequences in the field of immunogenicity
First Use:
2017-10-20
International Classes:
042 - Primary Class
Class Status:
ACTIVE
For:
Health screening services in the field of immunogenicity; Providing medical information to scientists in the form of reports in the field of immunogenicity
First Use:
2017-10-20
International Classes:
044 - Primary Class
Class Status:
ACTIVE
Serial Number:
87294409
Mark:
EPIMATRIX
Status:
A Sections 8 and 15 combined declaration has been accepted and acknowledged.
Mark Type:
Service Mark
Application Filing Date:
2017-01-09
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
EPIMATRIX
USPTO Link:
View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:
Research, development, engineering and testing services in the fields of proteins and T cell vaccines; Providing temporary use of non- downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines
First Use:
1998-05-20
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
87293011
Mark:
PREDEFT
Status:
A Sections 8 and 15 combined declaration has been accepted and acknowledged.
Mark Type:
Service Mark
Application Filing Date:
2017-01-08
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
PREDEFT
USPTO Link:
View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:
Scientific and technical services, namely, analysis and testing of protein therapeutic sequences in the field of immunogenicity
First Use:
2001-06-20
International Classes:
042 - Primary Class
Class Status:
ACTIVE

Reviews Leave a review

This company hasn't received any reviews.

Related by address

188 VALLEY STREET SUITE 424, PROVIDENCE, RI, 02909, USA

EpiVax, Inc.
Domestic Profit Corporation
EpiVax, Inc., which currently Conversion, had registered address 188 VALLEY STREET SUITE 424, PROVIDENCE, RI, 02909, USA.
GAIA Vaccine Foundation
Domestic Non-Profit Corporation
GAIA Vaccine Foundation, which currently Activ, has registered address 188 VALLEY STREET SUITE 424, PROVIDENCE, RI, 02909, USA.
EpiVax Therapeutics, Inc.
Foreign Corporation
EpiVax Therapeutics, Inc., which currently Activ, has registered address 188 VALLEY STREET SUITE 424, PROVIDENCE, RI, 02909, USA.

Date of last update: 11 Jul 2025

Sources: Rhode Island Department of State

Privacy policy Policy
About us About us Business Directory
Contacts Contact us

© 2025 riorgs.com, Part of Big Data Integrated